Edwin M Kania Jr's Net Worth

$5.73 Billion

Estimate Recalculated Feb 29, 2024 04:46PM EST

Who is Edwin M Kania Jr?

Edwin M Kania Jr has an estimated net worth of $5.73 Billion. This is based on reported shares across multiple companies, which include Moderna, Inc., Kaleido Biosciences, Inc., TETRAPHASE PHARMACEUTICALS INC, AGIOS PHARMACEUTICALS INC, BG Medicine, Inc., BIND Therapeutics, Inc, Receptos, Inc., Seres Therapeutics, Inc., Editas Medicine, Inc., TransMedics Group, Inc., Quanterix Corp, CONCERT PHARMACEUTICALS, INC., SELECTA BIOSCIENCES INC, Rubius Therapeutics, Inc., Syros Pharmaceuticals, Inc., Eleven Biotherapeutics, Inc., T2 Biosystems, Inc., Axcella Health Inc., Evelo Biosciences, Inc., HELICOS BIOSCIENCES CORP, ACCELERON PHARMA INC, ASPECT MEDICAL SYSTEMS INC, and EXACT SCIENCES CORP.

SEC CIK

Edwin M Kania Jr's CIK is 0001255927

Past Insider Trading and Trends

2014 was Edwin M Kania Jr's most active year for acquiring shares with 41 total transactions. Edwin M Kania Jr's most active month to acquire stocks was the month of November. 2014 was Edwin M Kania Jr's most active year for disposing of shares, totalling 74 transactions. Edwin M Kania Jr's most active month to dispose stocks was the month of November. 2023 saw Edwin M Kania Jr paying a total of $19,339,965.52 for 245,586 shares, this is the most they've acquired in one year. In 2014 Edwin M Kania Jr cashed out on 31,853,123 shares for a total of $43,535,243.88, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Moderna, Inc. (MRNA) Snapshot price: $99.22

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-95.22%
-475.00K
$20.26
-$9,623,813.34
23.85K
Jan 10 - Jan 14
Form 4
-16.70%
-100.00K
$18.81
-$1,880,840.00
498.85K
Dec 10
Form 4
-5.75%
-9.67M
$18.87
-$8,196,935.61
158.57M
Dec 9 - Dec 11
Form 4
47.34M
47.34M
Dec 11
Form 3
0
0
No matching records found

Kaleido Biosciences, Inc. (KLDO) Snapshot price: $0.000001

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+158.12%
1.12M
1.83M
Mar 4
Form 3
0
0
No matching records found

TETRAPHASE PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.06M
$7.00
2.06M
Mar 25
Form 3
0
0
No matching records found

AGIOS PHARMACEUTICALS INC (AGIO) Snapshot price: $23.765

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-50.00%
-1.93M
1.93M
Jun 23
Form 4
3.86M
3.86M
Jul 29
Form 3
0
0
No matching records found

BG Medicine, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jul 14
Form 4
-100.00%
-634.39K
$0.32
-$200,536.80
0
Dec 9 - Dec 11
Form 4
634.39K
634.39K
Dec 4
Form 4
-92.41%
-2.26M
$0.24
$174.72
185.75K
Dec 3 - Dec 4
Form 4
-100.00%
-640.37K
$0.24
$198.60
0
Dec 3 - Dec 4
Form 4
-100.00%
-92.29K
$0.24
$21.10
0
Dec 3 - Dec 4
Form 4
-100.00%
-92.13K
$0.24
$20.72
0
Dec 3 - Dec 4
Form 4
+33.80%
2M
$2.00
$4,000,000.00
7.92M
Jan 30
Form 4
-100.00%
-276.60K
$2.93
-$22.15
0
Aug 20 - Aug 21
Form 4
-100.00%
-104.93K
$1.99
-$10.38
0
May 21 - May 23
Form 4
-64.80%
-193.13K
104.93K
Sep 19
Form 4
+233.07%
4.73M
$7.00
$6,084,547.00
6.76M
Sep 27 - Feb 9
Form 3
0
0
No matching records found